Published • loading... • Updated
Early Use of the Drug "Mongaro" Helps in Treating Diabetes
Summary by cedarnews.net
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
This article was originally published on Cedarnews.net. For more news and exclusive reports, visit our website. A study funded by Eli Lilly showed that adding the drug terzepatide (Mongaro) to type 2 diabetes patients who had not responded to initial treatment improved blood sugar and weight control after two years, compared to other GLP-1 inhibitors. Approximately 60% of Mongaro users achieved normal blood sugar levels, compared to 24% in the c…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
